Benzofuran and quinoline carboxamides and quinoline sulfonamides as TNF inhibitors and as PDE4 inhibitors

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.8, Iss.7, 1998-07, pp. : 899-905

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quinoline-based HIV Integrase Inhibitors

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1835-1849

Bentham Science Publishers

Access to resources Recommend Favorite

PDE4 inhibitors 1998

By Norman P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 771-784

Informa Healthcare

Access to resources Recommend Favorite

PDE4 inhibitors 1999

By Norman P.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 8, 1999-08 ,pp. : 1101-1118

Informa Healthcare

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of 4-(Imidazolylmethyl)-2- Aryl-Quinoline Derivatives as Aromatase Inhibitors and Anti-breast Cancer Agents

Letters in Drug Design & Discovery, Vol. 13, Iss. 1, 2015-10 ,pp. : 89-97

Bentham Science Publishers

Access to resources Recommend Favorite

Dialkoxypyridylalkylimidazolidine PDE4B inhibitors

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 3, 2000-03 ,pp. : 357-359

Informa Healthcare

Access to resources Recommend Favorite